International Flavors & Fragrances

Charles Schwab

Raytheon Technologies

Altria

Campbell Soup

Biogen

Masco

U.S. Bancorp

Medtronic

Pfizer

VanEck Morningstar Wide Moat Value ETF

MVAL tracks a modified equal-weighted index of 30 to 60 value-oriented US stocks that Morningstar determines to be attractively priced and have sustainable competitive advantages.

VanEck Morningstar Wide Moat Growth ETF

VanEck Morningstar Wide Moat ETF

Vaneck Morningstar SMID Moat ETF

By Brandon Rakszawski, Director of Product Management April was a reset month for US equity markets, as investors digested persistent inflation data and declining GDP growth. It was the first negative month of the year, from a total return perspective, pausing what had been a consistent upward trajectory for US stocks to start the year.

Moat Stocks React to Inflation and Slowing Growth

When it comes to the combination of wide moat investing and exchange traded funds, the VanEck Morningstar Wide Moat ETF (MOAT) sets the standard. MOAT turns 12 years old next week and now has $14.4 billion in assets under management as well as a lengthy track record of beating broader, old-guard equity benchmarks.

2 Fresh Takes on Wide Moat Investing

On Thursday, VanEck added two new ETFs to its growing ETF roster – the VanEck Morningstar Wide Moat Value ETF (MVAL) and the VanEck Morningstar Wide Moat Growth ETF (MGRO). Both funds seek exposure to companies with good valuation and a wide moat rating.

VanEck Launches Wide Moat ETFs for Value and Growth

MVAL and MGRO join MOAT and other ETFs in suite of funds built around Morningstar's proven strategy of identifying quality companies with distinct economic moats trading at attractive valuations.

News for VanEck Morningstar Wide Moat Value ETF ETF (MVAL)